Food and Drug Administration (FDA) announced a semaglutide warning label update on September 22, 2023, warning that Ozempics warning label would be updated to include certain gastrointestinal side effects on September 22, 2023
The panel below is his CGM 6 months after taking Tirzepatide 5 mg, without a major change in his diet or lifestyle during which time his weight dropped 7 Kg and his HbA1C dropped from a prediabetic value of 44 to 34 mmol/mol
Ozempic is one of the most-prescribed drugs in Canada, with more than a million people taking it, according to Novo Nordisk
This intermediate dose offers a strong balance between efficacy and tolerability, making it a popular choice for many research applications
It also helps wounds heal
Patients should know about allodynia as a possibility, understand what to watch for, and have a plan for what to do if symptoms develop